Bayreuther C, Borg M, Ferrero-Vacher C, Chaussenot A, Lebrun C
Service de neurologie, hôpital Pasteur, CHU de Nice, 30, voie Romaine, 06002 Nice, France.
Rev Neurol (Paris). 2010 Jan;166(1):100-3. doi: 10.1016/j.neurol.2009.03.005. Epub 2009 Jun 3.
Chorea-acanthocytosis (ChAc) is one of the neuroacanthocytosis syndromes which form a group of disorders characterized by the association of neurological abnormalities and spiculated red blood cells called acanthocytes. ChAc patients exhibit involuntary movements, psychiatric abnormalities and progressive cognitive deterioration. We report a case of ChAc in which blood smears failed to demonstrate acanthocytes.
A 26-year-old man presented since two years with hyperkinetic movements. The family history was non contributive, parents were consanguineous. Neurological examination revealed choreatic hyperkinesia and dystonia, predominant in the orofacial region. Mild cognitive decline and behavior abnormalities were noted with repetitive activities. Brain MRI showed striatal atrophy. Molecular testing for Huntington's disease was negative. Routine biological screening was normal except for elevated CPK and LDH. Copper and ceruloplasmin blood levels were normal, as well as purine metabolism and lipoproteins. Further screening for metabolic diseases showed no significant abnormality. Expression of Kell antigens was normal. In several blood smears no acanthocytes were seen. Electromyographic studies showed slight neuropathic changes. Despite the absence of acanthocytes, chorein western blot was performed on blood samples which revealed an absent or markedly reduced level of chorein in erythrocyte membranes. A mutation of the ChAc gene was thus likely so the diagnosis of ChAc was retained. Genetic studies for VPS13A are pending.
ChAc is an autosomal recessive disorder due to mutations of the VPS13A gene coding for chorein. Absence or late appearance of acanthocytes in ChAc has been described in a few case reports. In conclusion ChAc is a rare disorder in which the presence of acanthocytes is not mandatory. In case of doubt, chorein western blot can be useful.
舞蹈病-棘红细胞增多症(ChAc)是神经棘红细胞增多症综合征之一,这类疾病的特征是神经功能异常与称为棘红细胞的有刺红细胞同时出现。ChAc患者表现出不自主运动、精神异常和进行性认知衰退。我们报告一例ChAc病例,该病例的血液涂片未显示棘红细胞。
一名26岁男性,两年来一直有运动过多的症状。家族史无特殊意义,父母为近亲结婚。神经系统检查发现舞蹈样运动过多和肌张力障碍,以口面部区域为主。注意到有轻度认知衰退和行为异常,伴有重复性活动。脑部MRI显示纹状体萎缩。亨廷顿舞蹈病的分子检测为阴性。常规生化筛查除肌酸磷酸激酶(CPK)和乳酸脱氢酶(LDH)升高外均正常。血液中的铜和铜蓝蛋白水平正常,嘌呤代谢和脂蛋白也正常。进一步的代谢疾病筛查未发现明显异常。凯尔抗原的表达正常。在几张血液涂片中未见到棘红细胞。肌电图研究显示有轻微的神经病变改变。尽管没有棘红细胞,但对血液样本进行了舞蹈蛋白免疫印迹检测,结果显示红细胞膜中舞蹈蛋白缺失或水平明显降低。因此很可能存在ChAc基因的突变,所以确诊为ChAc。VPS13A基因的遗传学研究正在进行中。
ChAc是一种常染色体隐性疾病,由编码舞蹈蛋白的VPS13A基因突变引起。少数病例报告中描述了ChAc患者棘红细胞缺失或出现较晚的情况。总之,ChAc是一种罕见疾病,棘红细胞的存在并非必要条件。如有疑问,舞蹈蛋白免疫印迹检测可能会有帮助。